期刊文献+

夜明砂药材标准及炮制规范的现状及相关问题探讨 被引量:3

Discussion on the status and related issues of the medicinal materials standards and processing practice of Yemingsha(bat dung)
原文传递
导出
摘要 本文对夜明砂法定药材标准、炮制规范及含夜明砂的已上市中成药的质控现状进行了回顾分析,就基原、炮制、安全用药等方面的问题进行了探讨。建议:①加强夜明砂药材的专属性鉴别研究,并明确采集时感染病毒等病原微生物的风险及个人防护注意事项。②参照古法对夜明砂进行水洗、炒制等处理,提高饮片用药的安全性。③对于夜明砂直接粉碎入药的已上市中成药应加强研究,采用合适的炮制方法,必要时增加病毒等病原微生物的灭活工艺。④对于处方中使用夜明砂的中药新药,应加强相关研究,充分说明夜明砂入药的科学性、必要性,保证新药安全有效。 This article reviewed and analyzed the current quality standards of Yemingsha's statutory medicinal materials,processing practice,and quality control status of marketed Chinese patent medicines containing Yemingsha,and discussed issues such as the origin,processing,and safe use of the medicines.Some suggestions were put forward.Firstly,it is necessary to strengthen the specific identification research of Yemingsha medicinal materials,and clarify the risk of pollution by pathogenic microorganisms such as viruses and personal precautions during collection.Secondly the ancient method should be followed to wash and fry Yemingsha to improve the safety of decoction pieces.Thirdly it is necessary to strengthen research on the marketed Chinese patent medicines for which Yemingsha is crushed directly into the medicine and adopt appropriate processing methods,and inactivation process of pathogenic microorganisms such as viruses should be added if necessary.Lastly for the novel traditional Chinese medicines that use Yemingsha in the prescriptions,relevant research should be carried out to fully explain the scientificity and necessity of adding Yemingsha to ensure that the new medicines are safe and effective.
作者 李灿 周跃华 LI Can;ZHOU Yue-hua(Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China)
出处 《中国新药杂志》 CAS CSCD 北大核心 2020年第16期1851-1855,共5页 Chinese Journal of New Drugs
关键词 夜明砂 药材标准 炮制规范 Yemingsha(bat dung) medicinal material standard processing specification
  • 相关文献

参考文献2

二级参考文献35

  • 1梁子安,李远香.我国蝙蝠研究近况[J].南阳师范学院学报,2005,4(9):57-64. 被引量:7
  • 2于恩庶,徐国英,刘岱伟,颜苹苹.蝙蝠对人兽共患病的传播作用[J].中国人兽共患病学报,2006,22(5):450-455. 被引量:12
  • 3潘清华,王应祥,岩昆.中国哺乳动物彩色图鉴[M].北京:中国林业出版社,2006,371-376.
  • 4李志峰,俞守义,吴毅.广西岭景镇某山村蝙蝠携带SARS样冠状病毒及狂犬病毒的调查研究[J].医学动物防制,2007,23(10):721-723. 被引量:7
  • 5Badrane H, Bahloul C, Perrin P, et al. Vidence of two lyssavirus phylogroups with distinct pathogenicity and immunogenicity [ J]. Journal of Virology,2001,75:3268-3276.
  • 6Botvinkin A D, Poleschuk E M, Kuzmin I V. Novel lyssaviruses isolated from bats in Russia[ J]. Emerging Infectious Disea- ses, 2003,9 : 1623-1625.
  • 7Pape W J, Fitssimmons T D, Hofman R E. Risk for rabies transmission from encounters with bats[ J]. Emerging Infectious Dis- eases, 1999,5:433-437.
  • 8World Health Organization. The programme on human rabies surveillance and control [ EB/OL 1. [ 2012-9-19 ]. http://www.who. int/emc/diseases/zoo/rabies, html.
  • 9Guan Y, Zheng B J, He Y Q, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China[ J 1. Science, 2003,302:276-278.
  • 10Song H D, Tu C C, Zheng G W, et al. Cross host evolution of severe acute respiratory syndrome coronavirus in palm civet and human[ J]. Proc Natl Acad Sci USA, 2005,102:2430-2435.

共引文献8

同被引文献77

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部